HDFC Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund

Portfolio Overlap Analysis · SBI vs HDFC

54.8%
High Overlap
16 common stocks · Rank #765 of 28,282 pairs
Fund A
HDFC Pharma and Healthcare Fund
HDFC · Sectoral - Pharma
Fund B
SBI Healthcare Opportunities Fund
SBI · Sectoral - Pharma

Common Holdings (10)

StockWt% in HDFC Pharma and HealthcareWt% in SBI Healthcare OpportunitiesOverlap
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
9.81%10.65%9.81%
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
8.38%7.55%7.55%
Max Healthcare Institute Ltd.
Healthcare Services
6.36%4.82%4.82%
Lupin Ltd.
Pharmaceuticals & Biotechnology
6.44%4.23%4.23%
Aster DM Healthcare Ltd.
Healthcare Services
5.42%3.85%3.85%
Acutaas Chemicals Ltd.
Pharmaceuticals & Biotechnology
3.60%4.77%3.60%
Fortis Healthcare Ltd.
Healthcare Services
4.02%3.24%3.24%
Krishna Institute of Medical Sciences Ltd.
Healthcare Services
3.61%2.92%2.92%
Laurus Labs Ltd.
Pharmaceuticals & Biotechnology
2.91%3.48%2.91%
Alkem Laboratories Ltd.
Pharmaceuticals & Biotechnology
6.21%2.77%2.77%

Unique to HDFC Pharma and Healthcare

  • Glenmark Pharmaceuticals Ltd.6.62%
  • Ipca Laboratories Ltd.4.80%
  • Anthem Biosciences Limited4.46%

Unique to SBI Healthcare Opportunities

  • Apollo Hospitals Enterprise Ltd.5.76%
  • Torrent Pharmaceuticals Ltd.4.25%
  • Biocon Ltd.3.59%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
39.4% (11)
Healthcare Services
15.4% (5)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC Pharma and Healthcare

More comparisons for SBI Healthcare Opportunities

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.